We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pennsylvania Drugmaker Warned for Labeling and Testing Issues
Pennsylvania Drugmaker Warned for Labeling and Testing Issues
FDA hit High Chemical Company with a warning letter over CGMP deviations for active pharmaceutical ingredients (API) it manufactured at its Levittown, Pennsylvania facility.